If you are a member of the network, please log in to access Network content and tools. If you do not have a username, contact your site principal investigator or site coordinator and request that they complete a membership request for you. If you have forgotten your password, you may CLICK HERE.


You are here


Export 155 results:
Author Title Type [ Year(Desc)]
Filters: Type is Conference Abstract  [Clear All Filters]
Kanne SM, Gage NA, Lierheimer KS. The Interrelationship Between Receptive Language and Behavior in Children with ASD: Exploration to Inform Pivotal Interventions. IMFAR. 2011.
Reynolds AM, Molloy CA, S. James J, Johnson CR, Clemons TE, Hyman SL. Iron Status in Children with ASD. IMFAR. 2011.
Barnes G, Coury DL, Loh A, Sidhu N, Clemons TE. Medical Comorbidities in Children with Epilepsy and Autism Spectrum Disorders. IMFAR. 2011.
Coury DL. Medical Comorbidities In Children with Epilepsy and Autism Spectrum Disorders. SDBP. 2011.
Stewart PA, Lemcke N, Schmidt BL, Wixom N, Clemons TE, Peck R, et al.. Nutrient intake and supplement use in children with autism spectrum disorders. Do multivitamins provide the nutrients consumed in low amounts?. IMFAR. 2011.
Adkins KW, Molloy CA, Reynolds AM, Clemons TE, Goldman SE, Surdyka K, et al.. Parent Sleep Education in Autism: Effect of a Standardized Pamphlet on Sleep Latency. PAS. 2011.
Hyman SL, Cole L, Reynolds AM, Clemons TE, Coury DL. Persistence of Complementary and alternative medicine use in ASD. IMFAR. 2011.
Vasa RA, Kalb LG, Clemons TE, Freedman B, Keefer A, Kanne SM, et al.. Prevalence of anxiety and associated psychiatric comorbidities among children with Autism Spectrum Disorder: an Autism Treatment Network Study. IMFAR. 2011.
Blum NJ, Coury DL, Feldman H, Perrin JM. Rationale, Development and Collaboration with Clinical Research Networks: The ATN and DBPNet. SDBP. 2011.
Barnes G, Malow BA, Fuchs G, Bernal MPilar, Sidhu N. Recommendations for Evaluation and Treatment of Medical Co-Morbidities in ASD. IMFAR. 2011.
Foley JT. Regression and autism: the answer depends on the question. IMFAR. 2011.
Johnson SL, Austin H, Withrow NL, Hsueh E, Waggoner A, Reynolds AM. Relations Between Caregiver Perceptions of Problematic Mealtime Behaviors and Caregiver Feeding Practices. IMFAR. 2011.
Kalb LG, Keefer A, Foster C, Vasa RA, Freedman B, Zablotsky B. Risk factors for Aggressive Behavior in Youth with an Autism Spectrum Disorder. IMFAR. 2011.
Reynolds AM, Cole L, Panzer R, Treadwell-Deering D, McCoy R, Anagnostou E, et al.. Side effect monitoring of children with ASD prescribed Second Generation Antipsychotics (SGAs). IMFAR. 2011.
Coury DL, Manning-Courtney P, Reynolds AM, Anagnostou E. Use of Psychotropic Medications in Autism Spectrum Disorders (ASD): An Autism Treatment Network Study. IMFAR. 2011.
Williams K, Fuchs G, Clemons TE, Rhoda D, Rosenberg D. Association Of Chronic Gastrointestinal Symptoms With Sleep Problems May Help Identify Distinct Subgroups of Autism Spectrum Disorders. DDW. 2012.
Wodka EL. Autism Symptom Severity as Moderator of IQ and Language Development among Children with Delayed Phrase Speech and Autism Spectrum Disorder. IMFAR. 2012.
Williams K, Fuchs G, Clemons TE, Rosenberg D, Rhoda D. Chronic GI Symptoms in Children with Autism Spectrum Disorders are Associated with Clinical Anxiety. DDW. 2012.
Bellando J, Katz TF, Leuthe E, Clemons TE. Cognitive Assessment of Children with ASD. IMFAR. 2012.
Butter E, Arendt R. Cognitive Profile in Higher Functioning Children with An Autism Spectrum Disorder. IMFAR. 2012.
Smith D. Database Structure for Multiple Protocols Within a Project. SOCIETY FOR CLINICAL TRIALS. 2012.
Austin H, Katz TF, Reyes JPM. Development of a Training Video to Teach Best Practices for Delivering an ASD Diagnosis to Families. IMFAR. 2012.
Vasa RA, Kalb LG, Freedman B, Keefer A, Kanne SM, Mazurek MO. Differential Perceptions of Clinical Anxiety Among Clinicians and Parents in Children with Autism Spectrum Disorder. IMFAR. 2012.
Neumeyer AM, Gates A, Ferrone C, Misra M. The Effect of Autism on Bone Metabolism in Peripubertal Boys. IMFAR. 2012.
Kanne SM, Mazurek MO, Bellando J, Freedman B, Sikora DM, Handen BL, et al.. Initial Psychometric Properties of the Autism Impact Measure (AIM): A New Tool for Treatment Outcome Measurement. IMFAR. 2012.